Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
|
|
Bellerophon Therapeutics, Inc. (BLPH)
|
|
| Operating Efficiency |
|
|
|
|
Annual |
|
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| | Source | Source | Source | Source | Source | Source | Source | Source |
| Turnover Ratios |
| Asset turnover | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.9 |
| |
| Returns on Capital |
| ROIC (excluding intangibles) | | | | | | -407.8% | -136.8% | -297.1% |
| ROIC (including intangibles) | 493.4% | 1092.1% | 450.3% | 398.9% | -598.7% | -1047.1% | -240.1% | -190.9% |
| ROE | -787.4% | -84.7% | -63.3% | -428.4% | 775.1% | 948.3% | -129.7% | -153.5% |
| ROA | -251.4% | -68.1% | -48.2% | -117.4% | 162.8% | -66.8% | -78.5% | -121.2% |
| |
| Cash Conversion Cycle |
| Days sales outstanding | | | | | | | | 0.0 |
| Days payables outstanding | | | | | | | | 18.6 |
| Cash conversion cycle | | | | | | | | -18.6 |
|